30 results on '"Gurmu, Yared"'
Search Results
2. The Effect of PCSK9 Inhibition on the Risk of Venous Thromboembolism
3. Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients With Cardiometabolic Disease
4. The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism
5. Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease Using a Genetic Risk Score: Results From the FOURIER Trial
6. Heart Failure Risk Stratification and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus
7. Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial
8. Clinical Outcomes in Patients With Acute Decompensated Heart Failure Randomly Assigned to Sacubitril/Valsartan or Enalapril in the PIONEER-HF Trial
9. Long‐Term Ticagrelor in Patients With Prior Coronary Stenting in the PEGASUS‐TIMI 54 Trial
10. Efficacy and Safety of Sacubitril/Valsartan in High-Risk Patients in the PIONEER-HF Trial
11. Genetic Risk Score to Identify Risk of Venous Thromboembolism in Patients With Cardiometabolic Disease
12. Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS‐TIMI 54 Trial
13. Gut Microbiota‐Dependent Trimethylamine N‐oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS‐TIMI 54 Trial
14. PERFORMANCE OF A NOVEL GENETIC RISK SCORE TO IDENTIFY RISK OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH CARDIOMETABOLIC DISEASE
15. A Sexual Partnership Duration: Characterizing Sampling Conditions That Permit unbiased Estimation of Survivorship and Effect on It of Covariates
16. Cardiac and Inflammatory Biomarkers Are Associated with Worsening Renal Outcomes in Patients with Type 2 Diabetes Mellitus: Observations from SAVOR-TIMI 53
17. Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial
18. NATRIURETIC PEPTIDES VERSUS A CLINICAL HISTORY OF HEART FAILURE FOR RISK PREDICTION IN PATIENTS WITH DIABETES
19. INFLAMMATORY AND CARDIAC BIOMARKERS ARE ASSOCIATED WITH RENAL OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: INSIGHTS FROM SAVOR-TIMI 53
20. Risk Assessment in Patients With Diabetes With the TIMI Risk Score for Atherothrombotic Disease
21. Predicting Subnational Ebola Virus Disease Epidemic Dynamics from Sociodemographic Indicators
22. Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular risk.
23. Risk Assessment in Patients With Diabetes With the TIMI Risk Score for Atherothrombotic Disease.
24. Modeling and Estimation of Patterns of Relationship Formation and Dissolution
25. Abstract 13865: Trimethylamine N-Oxide Levels and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: Data From PEGASUS-TIMI 54 Trial
26. Abstract 14894: Performance of a Genome-Wide Polygenic Risk Score to Predict Coronary Events in Patients With Diabetes Without Prior Myocardial Infarction
27. Abstract 14720: Performance of a Novel Genetic Risk Score to Identify Residual Risk of Ischemic Stroke in Patients Anticoagulated for Atrial Fibrillation
28. Abstract 13838: Efficacy and Safety of Sacubitril/Valsartan in Acute Decompensated Heart Failure in High-Risk Patients in the PIONEER-HF Trial
29. Abstract 14143: Caffeine and Dyspnea With Ticagrelor: A Sub-Analysis From PEGASUS TIMI-54 Trial.
30. A Sexual Partnership Duration: Characterizing Sampling Conditions That Permit unbiased Estimation of Survivorship and Effect on It of Covariates.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.